GMTX

Gemini Therapeutics, Inc. /DECIK 1816736 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for GMTX PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for GMTX

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Leonard Braden Michael	10% Owner	5	$1.34M	$47.0K	2022-10-26
Piekos Brian	Chief Financial Officer	5	$72.4K	$0	2022-05-31
Meyenburg Jason Patrick	President & CEO	3	$123.0K	$0	2022-01-03
GEMAYEL GEORGES	See Remarks	4	$0	$0	2022-01-03
Ong Tuyen	Director	4	$0	$0	2021-10-04
Tananbaum James B.	Director, 10% Owner	4	$0	$0	2021-10-04
Rhodes Jason P	Director, 10% Owner	1	$0	$0	2021-10-04
Lubner David Charles	Director	5	$0	$0	2021-10-04
GORDON CARL L	Director, 10% Owner	1	$0	$0	2021-10-04
Strapps Walter	Chief Scientific Officer	3	$0	$0	2021-04-29
Barone Samuel B.	Chief Medical Officer	1	$0	$0	2021-04-12
Redmond Precillia	Chief People Officer	2	$0	$0	2021-02-23
Lauder Scott	Chief Technology Officer	2	$0	$0	2021-02-23
Uknis Marc	Chief Medical Officer	1	$0	$0	2021-02-05
Foresite Capital Opportunity Management V, LLC	10% Owner	3	$0	$0	2021-02-05

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Leonard Braden Michael	10% Owner	S Sale	2022-10-26	2022-10-27	22,500	$2.09	$47.0K	247,500	SEC↗
Piekos Brian	CFO	A Award	2022-05-31	2022-06-02	9,960	$1.09	$10.9K	17,615	SEC↗
Leonard Braden Michael	10% Owner	P Buy	2022-04-13	2022-04-13	191,769	$1.52	$291.5K	5,000,000	SEC↗
Leonard Braden Michael	10% Owner	P Buy	2022-04-12	2022-04-13	55,000	$1.37	$75.3K	270,000	SEC↗
Leonard Braden Michael	10% Owner	P Buy	2022-04-12	2022-04-13	203,744	$1.42	$289.3K	4,808,231	SEC↗
Leonard Braden Michael	10% Owner	P Buy	2022-04-11	2022-04-13	504,487	$1.35	$681.1K	4,604,487	SEC↗
Piekos Brian	CFO	A Award deriv	2022-01-13	2022-01-14	280,876	—	$0	280,876	SEC↗
GEMAYEL GEORGES	Executive Chair of the Board	A Award deriv	2022-01-03	2022-01-05	793,274	—	$0	793,274	SEC↗
Meyenburg Jason Patrick	Chief Executive Officer	A Award deriv	2022-01-03	2022-01-05	123,600	—	$0	123,600	SEC↗
GEMAYEL GEORGES	See Remarks	A Award deriv	2021-11-15	2021-11-16	23,514	—	$0	23,514	SEC↗
GEMAYEL GEORGES	See Remarks	A Award deriv	2021-11-15	2021-11-16	17,245	—	$0	17,245	SEC↗
Piekos Brian	Chief Financial Officer	A Award deriv	2021-10-18	2021-10-20	90,720	—	$0	90,720	SEC↗
Lubner David Charles	Director	A Award deriv	2021-10-04	2022-03-09	0	—	$0	0	SEC↗
Ong Tuyen	Director	A Award deriv	2021-10-04	2022-03-09	15,528	—	$0	15,528	SEC↗
Lubner David Charles	Director	A Award deriv	2021-10-04	2021-10-06	17,245	—	$0	17,245	SEC↗
Ong Tuyen	Director	A Award deriv	2021-10-04	2021-10-06	17,245	—	$0	17,245	SEC↗
Rhodes Jason P	Director, 10% Owner	A Award deriv	2021-10-04	2021-10-06	17,245	—	$0	17,245	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2021-10-04	2021-10-06	17,245	—	$0	17,245	SEC↗
Tananbaum James B.	Director, 10% Owner	A Award deriv	2021-10-04	2021-10-06	17,245	—	$0	17,245	SEC↗
Piekos Brian	Chief Financial Officer	P Buy	2021-05-14	2021-05-18	7,655	$9.46	$72.4K	7,655	SEC↗
Meyenburg Jason Patrick	President & CEO	P Buy	2021-05-14	2021-05-18	13,000	$9.46	$123.0K	13,000	SEC↗
Strapps Walter	Chief Scientific Officer	A Award deriv	2021-04-29	2021-05-03	9,000	—	$0	9,000	SEC↗
GEMAYEL GEORGES	Director	A Award deriv	2021-04-29	2021-05-03	45,466	—	$0	45,466	SEC↗
Barone Samuel B.	Chief Medical Officer	A Award deriv	2021-04-12	2021-04-14	255,212	—	$0	255,212	SEC↗
Piekos Brian	Chief Financial Officer	A Award deriv	2021-04-12	2021-04-14	377,734	—	$0	377,734	SEC↗
Lubner David Charles	Director	A Award deriv	2021-03-12	2022-03-09	17,529	—	$0	17,529	SEC↗
Lubner David Charles	Director	A Award deriv	2021-03-12	2021-03-15	25,000	—	$0	25,000	SEC↗
Ong Tuyen	Director	A Award deriv	2021-03-12	2021-03-15	15,000	—	$0	15,000	SEC↗
Strapps Walter	Chief Scientific Officer	A Award deriv	2021-03-01	2021-03-03	99,133	—	$0	99,133	SEC↗
Lauder Scott	Chief Technology Officer	A Award deriv	2021-02-23	2021-02-25	272,615	—	$0	272,615	SEC↗
Redmond Precillia	Chief People Officer	A Award deriv	2021-02-23	2021-02-25	25,489	—	$0	25,489	SEC↗
Lauder Scott	Chief Technology Officer	A Award deriv	2021-02-05	2021-04-07	243,996	—	$0	243,996	SEC↗
Meyenburg Jason Patrick	President & CEO	A Award deriv	2021-02-05	2021-04-07	1,124,832	—	$0	1,124,832	SEC↗
Redmond Precillia	Chief People Officer	A Award deriv	2021-02-05	2021-04-07	77,450	—	$0	77,450	SEC↗
Strapps Walter	Chief Scientific Officer	A Award deriv	2021-02-05	2021-04-07	79,094	—	$0	79,094	SEC↗
Uknis Marc	Chief Medical Officer	A Award deriv	2021-02-05	2021-04-07	277,117	—	$0	277,117	SEC↗
Lubner David Charles	Director	A Award deriv	2021-02-05	2021-04-07	58,855	—	$0	58,855	SEC↗
Ong Tuyen	Director	A Award deriv	2021-02-05	2021-04-07	58,855	—	$0	58,855	SEC↗
Foresite Capital Opportunity M	10% Owner	C Conversion deriv	2021-02-05	2021-02-09	2,928,750	—	$0	0	SEC↗
Tananbaum James B.	Director	C Conversion deriv	2021-02-05	2021-02-09	2,928,750	—	$0	0	SEC↗
Foresite Capital Opportunity M	10% Owner	C Conversion	2021-02-05	2021-02-09	2,928,750	—	$0	2,928,750	SEC↗
Foresite Capital Opportunity M	10% Owner	A Award	2021-02-05	2021-02-09	1,500,000	$10.00	$15.00M	1,500,000	SEC↗
Tananbaum James B.	Director	C Conversion	2021-02-05	2021-02-09	2,928,750	—	$0	2,928,750	SEC↗
Tananbaum James B.	Director	A Award	2021-02-05	2021-02-09	1,500,000	$10.00	$15.00M	1,500,000	SEC↗